These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 16020804)

  • 21. Major medical complications of lung transplantation: a pediatric perspective.
    Mallory GB
    Semin Thorac Cardiovasc Surg; 1996 Jul; 8(3):305-12. PubMed ID: 8843523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral immunity and the development of obliterative bronchiolitis after lung transplantation: is there a link?
    Emtiazjoo AM; Wilkes DS
    Am J Respir Cell Mol Biol; 2013 Feb; 48(2):145-9. PubMed ID: 23087052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status and future of lung transplantation.
    Date H
    Intern Med; 2001 Feb; 40(2):87-95. PubMed ID: 11300168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
    Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung and heart-lung transplantation at University of Pittsburgh: 1982-2009.
    Thacker J; Toyoda Y
    Clin Transpl; 2009; ():179-95. PubMed ID: 20524284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-transplant bronchiolitis obliterans.
    Boehler A; Estenne M
    Eur Respir J; 2003 Dec; 22(6):1007-18. PubMed ID: 14680094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
    Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung transplantation: a decade of experience.
    Moffatt SD; Demers P; Robbins RC; Doyle R; Wienacker A; Henig N; Theodore J; Reitz BA; Whyte RI
    J Heart Lung Transplant; 2005 Feb; 24(2):145-51. PubMed ID: 15701428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung transplantation for cystic fibrosis: 6-year follow-up.
    Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
    J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Graft dysfunction, acute rejection and bronchiolitis obliterans in lung and heart-lung transplantation].
    Sleiman C; Groussard O; Mal H; Fournier M
    Rev Mal Respir; 1996 Nov; 13(5 Suppl):S31-40. PubMed ID: 9011909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical care management of the liver transplant recipient.
    Rudow DL; Goldstein MJ
    Crit Care Nurs Q; 2008; 31(3):232-43. PubMed ID: 18574371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation.
    Munster JM; van der Bij W; Breukink MB; van der Steege G; Zuurman MW; Hepkema BG; Verschuuren EA; van Son WJ; Seelen MA
    Transplantation; 2008 Dec; 86(12):1857-63. PubMed ID: 19104434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung transplantation at the turn of the century.
    DeMeo DL; Ginns LC
    Annu Rev Med; 2001; 52():185-201. PubMed ID: 11160774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung transplantation.
    Jenkinson SG; Levine SM
    Dis Mon; 1994 Jan; 40(1):1-38. PubMed ID: 8281876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity.
    Reinsmoen NL; Bolman RM; Savik K; Butters K; Matas AJ; Hertz MI
    J Heart Lung Transplant; 1994; 13(1 Pt 1):30-6; discussion 36-7. PubMed ID: 7513186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
    Bittner HB; Barten MJ; Binner C; Lehmann S; Garbade J; Hammerschmidt S; Wirtz H; Mohr FW
    Eur J Cardiothorac Surg; 2010 Sep; 38(3):268-76. PubMed ID: 20304665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection.
    Sumpter TL; Wilkes DS
    Am J Physiol Lung Cell Mol Physiol; 2004 Jun; 286(6):L1129-39. PubMed ID: 15136293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended donor criteria in lung transplantation: impact on organ allocation.
    Botha P; Trivedi D; Weir CJ; Searl CP; Corris PA; Dark JH; Schueler SV
    J Thorac Cardiovasc Surg; 2006 May; 131(5):1154-60. PubMed ID: 16678604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchiolitis obliterans following lung transplantation.
    Al-Githmi I; Batawil N; Shigemura N; Hsin M; Lee TW; He GW; Yim A
    Eur J Cardiothorac Surg; 2006 Dec; 30(6):846-51. PubMed ID: 17055283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended ganciclovir prophylaxis in lung transplantation.
    Perreas KG; McNeil K; Charman S; Sharples LD; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 2005 May; 24(5):583-7. PubMed ID: 15896756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.